510(k) Report

510(k) · Cleared

Cleared

BrainsWay Deep TMS System

K251391510(k) TraditionalCleared Nov 7, 2025186-day reviewClass II21 CFR 882.5805

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Brainsway, Ltd. · OBP Transcranial Magnetic Stimulator

Cleared on Nov 7, 2025 as substantially equivalent to K222196 (Brainsway, Ltd., 2024) and 1 other predicate after a 186-day review. Its family tree reaches back 12 generations to 2008.

Decided
Nov 7, 2025
Review
186 days
Class
Class II
Product code
OBP
Recalls
None
Predicates
2

Its longest line of descent runs back 12 generations to DEN070003 (2008). 26 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 12 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 8 generations between
  3. 3 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
  4. 2 generations backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
  5. 1 generation backK231926 NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc. · 2024 · Recalled
  6. This deviceK251391 BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025
Show all 12 generations
  1. Root · 12 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 11 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 10 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
  4. 9 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
  5. 8 generations backK143531 Rapid Therapy SystemMagstim Company Limited · 2015 · Recalled
  6. 7 generations backK160309 Neurosoft TMSTeleemg, LLC · 2016
  7. 6 generations backK171967 MagVita TMS Therapy SystemTonica Elektronik A/S · 2017
  8. 5 generations backK173620 Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S · 2018
  9. 4 generations backK193006 MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS…Tonica Elektronik A/S · 2020
  10. 3 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
  11. 2 generations backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
  12. 1 generation backK231926 NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc. · 2024 · Recalled
  13. This deviceK251391 BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12DEN070003Neurostar TMS SystemNeuronetics2008—
−11K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−10K130233Neurostar TMS Therapy SystemNeuronetics2013—
−9K133408Neurostar TMS Therapy SystemNeuronetics2014—
−8K143531Rapid Therapy SystemMagstim Company Limited20153
−7K160309Neurosoft TMSTeleemg, LLC2016—
−6K171967MagVita TMS Therapy SystemTonica Elektronik A/S2017—
−5K173620Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S2018—
−4K193006MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemTonica Elektronik A/S2020—
−3K212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced…Neuronetics, Inc.2022—
−2K230029NeuroStar Advanced Therapy System (Version 3.7)Neuronetics2023—
−1K231926NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc.20241
0 (this device)K251391BrainsWay Deep TMS SystemBrainsway, Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
201620
201730
201820
201910
202010
202110
202210
202410
FIG. 1 — Lineage of K251391, 2008–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBP device

  1. #1 K251119 MagVenture TMS Therapy Systemscore 21.8 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222196Deep TMS System
Summary page 5
…Class II Medical Device Predicate Device: The subject device is a substantially equivalent to the BrainsWay Deep TMSTM Systems (Model 102 and 104) cleared in 510(k) K222196 and to the NeuroStar Advanced Therapy System cleared in 510(k) K231926. Device M…
Brainsway, Ltd.2024—
*K231926NeuroStar Advanced Therapy System (All previously cleared models)
Summary page 5
…substantially equivalent to the BrainsWay Deep TMSTM Systems (Model 102 and 104) cleared in 510(k) K222196 and to the NeuroStar Advanced Therapy System cleared in 510(k) K231926. Device Manufacturer 510(k) No. BrainsWay Deep TMSTM System…
Neuronetics, Inc.20241

Also cleared against K222196: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 6 companies; a new generation was cleared every 1.1 years on median.
  • 3 of the 26 ancestors have a recall of any class.
  • 1 other device also cites its predicate K222196.

How does its category compare?

All OBP devices

OBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · OBP

12in 2025

2008: 22013: 22014: 12015: 22016: 32017: 82018: 42019: 32020: 12021: 52022: 62023: 72024: 52025: 122026 (partial year): 8
2007high 12 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBP

125in 2025

2016: 101 days median2017: 73 days median2018: 144 days median2019: 156 days median2021: 132 days median2022: 168 days median2023: 119 days median2024: 266 days median2025: 125 days median2026 (partial year): 176 days median
2007high 266 (2024) · low 73 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBP

1in 2018

2009: 12018: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBP

81in 2025

2009: 32011: 52012: 32013: 12015: 32016: 62017: 32018: 62019: 122020: 122021: 152022: 592023: 432024: 502025: 81
2007high 81 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—13
20100—00
20110—05
20120—03
20132—01
20141—00
20152—03
2016310106
201787303
2018414416
20193156012
20201—012
20215132015
20226168059
20237119043
20245266050
202512125081
202681761—

What is it indicated for?

The BrainsWay Deep TMS TM System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

The BrainsWay Deep TMS TM System is also indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (age 15-21 years).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251391: BrainsWay Deep TMS System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K251391

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026